Skip to content
Cerevance

Cerevance

CVN-424 is a small molecule dopamine signalling modulator aimed at improving motor impairment and managing "OFF" periods in Parkinson’s disease. It modulates dopamine signaling pathways to enhance motor control without directly stimulating dopamine receptors.

Cart 0

Your cart is currently empty.

Start Shopping